Yamada Hideyuki, Ishii Kumiko, Ishii Yuji, Ieiri Ichiro, Nishio Syunji, Morioka Takato, Oguri Kazuta
Laboratory of Molecular Life Science, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
J Toxicol Sci. 2003 Dec;28(5):395-401. doi: 10.2131/jts.28.395.
3H-Morphine at physiologic concentration was metabolized in vitro to its 3- and 6-glucuronides by human brain homogenate. Recombinant UGT2B7, one of the UDP-glucuronosyltransferase (UGT) isoforms, is able to glucuronidate the 3- and 6-hydroxy groups of morphine at nanomolar concentrations. These results suggest that endogenous morphine is converted to its 6-glucuronide, a more highly analgesic substance than the parent compound, to suppress effectively pain symptoms in humans.
生理浓度的3H-吗啡在体外被人脑匀浆代谢为其3-和6-葡糖醛酸苷。重组UGT2B7是尿苷二磷酸葡糖醛酸基转移酶(UGT)同工型之一,能够在纳摩尔浓度下将吗啡的3-和6-羟基葡糖醛酸化。这些结果表明,内源性吗啡被转化为其6-葡糖醛酸苷,一种比母体化合物镇痛作用更强的物质,从而有效抑制人类的疼痛症状。